HPV E6 protein regulation of the hTERT promoter
HPV E6 蛋白对 hTERT 启动子的调节
基本信息
- 批准号:7274152
- 负责人:
- 金额:$ 29.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-16 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:Applications GrantsBindingBinding SitesBiologicalBoxingCancer EtiologyCatalytic DomainCell Cycle ProteinsCell Differentiation processCell ProliferationCellsChromosomesDataDifferentiation and GrowthEventGene ExpressionGenesGenetic TranscriptionGoalsGrantHPV-High RiskHistone AcetylationHistone DeacetylaseHuman PapillomavirusIn VitroLaboratoriesLengthMaintenanceMalignant NeoplasmsMalignant neoplasm of cervix uteriMediatingMediator of activation proteinMolecularMultienzyme ComplexesNF-kappa BOncogene ProteinsOncogenicPapillomavirusPhenotypePlayProcessProtein OverexpressionProtein p53ProteinsPublishingRateRegulationRiskRoleTP53 geneTechniquesTelomeraseTransactivationTumor Suppressor ProteinsWomanZinc Fingersbasecell growthcell immortalizationchromatin immunoprecipitationgenetic regulatory proteinhuman RCN2 proteinhuman TERT proteinhuman UBE3A proteinin vivokeratinocytemalignant statemutantpromoterprotein functiontelomeretranscription factor
项目摘要
DESCRIPTION (provided by applicant): Worldwide, cervical cancer is the second leading cause of cancer in women and the "high risk" human papillomaviruses play a critical role in the genesis of this malignancy. The papillomaviruses encode two oncoproteins, E6 and E7, that are required for the initiation and maintenance of the malignant state as well as the induction of cell immortalization. Several of these biological activities appear related to the ability of E6 and E7 to degrade the cellular p53 and Rb tumor suppressor proteins, respectively. However, independent of its ability to degrade p53, E6 can induce cellular telomerase activity and, presumably, thereby maintain chromosome telomere length and continued cell proliferation. The rate-limiting event in cellular telomerase activity is the level of hTERT protein, the catalytic subunit of the enzyme complex. We and others have shown that the E6 protein transactivates the hTERT promoter, leading to an increase in hTERT protein and cellular telomerase activity. Our most recent studies indicate that the E6 protein associates with Myc protein and that they both bind and cooperatively activate the hTERT promoter. Interestingly, only the "high risk" E6 proteins bind the hTERT promoter, further supporting the correlation between induction of telomerase and cell immortalization. The current proposal investigates the mechanism by which E6 associates with Myc, binds the hTERT promoter, and facilitates gene transcription. In addition, we will examine whether E6 augments other Myc-regulated genes and whether Myc can mimic a subset of E6-specific cellular phenotypes. The overall goal of the grant is to gain an understanding of the role of E6 in regulating gene transcription, cell growth and cell differentiation.
描述(由申请人提供):在世界范围内,宫颈癌是女性癌症的第二大原因,“高危”人乳头瘤病毒在这种恶性肿瘤的发生中起着关键作用。乳头瘤病毒编码两种癌蛋白,E6和E7,这是恶性状态的起始和维持以及细胞永生化诱导所必需的。这些生物活性中的几种似乎分别与E6和E7降解细胞p53和Rb肿瘤抑制蛋白的能力有关。然而,独立于其降解p53的能力,E6可以诱导细胞端粒酶活性,并推测,从而维持染色体端粒长度和持续的细胞增殖。细胞端粒酶活性的限速事件是hTERT蛋白的水平,hTERT蛋白是酶复合物的催化亚基。我们和其他人已经表明,E6蛋白反式激活hTERT启动子,导致hTERT蛋白和细胞端粒酶活性的增加。我们最近的研究表明,E6蛋白与Myc蛋白相关联,它们都结合并协同激活hTERT启动子。有趣的是,只有“高风险”的E6蛋白结合hTERT启动子,进一步支持诱导端粒酶和细胞永生化之间的相关性。目前的建议调查E6与Myc,结合hTERT启动子,并促进基因转录的机制。此外,我们将研究E6是否增强其他Myc调控的基因,以及Myc是否可以模拟E6特异性细胞表型的子集。该基金的总体目标是了解E6在调节基因转录,细胞生长和细胞分化中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Schlegel其他文献
Richard Schlegel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Schlegel', 18)}}的其他基金
Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
- 批准号:
8547303 - 财政年份:2013
- 资助金额:
$ 29.8万 - 项目类别:
Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
- 批准号:
8899468 - 财政年份:2013
- 资助金额:
$ 29.8万 - 项目类别:
Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
- 批准号:
8727495 - 财政年份:2013
- 资助金额:
$ 29.8万 - 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
- 批准号:
8516613 - 财政年份:2011
- 资助金额:
$ 29.8万 - 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
- 批准号:
8725249 - 财政年份:2011
- 资助金额:
$ 29.8万 - 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
- 批准号:
8137493 - 财政年份:2011
- 资助金额:
$ 29.8万 - 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
- 批准号:
8322566 - 财政年份:2011
- 资助金额:
$ 29.8万 - 项目类别:
A topical treatment for genital papillomavirus infections
生殖器乳头瘤病毒感染的局部治疗
- 批准号:
7286845 - 财政年份:2006
- 资助金额:
$ 29.8万 - 项目类别:
A topical treatment for genital papillomavirus infections
生殖器乳头瘤病毒感染的局部治疗
- 批准号:
7174571 - 财政年份:2006
- 资助金额:
$ 29.8万 - 项目类别:
HPV E6 protein regulation of the hTERT promoter
HPV E6 蛋白对 hTERT 启动子的调节
- 批准号:
6757107 - 财政年份:2004
- 资助金额:
$ 29.8万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 29.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 29.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 29.8万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 29.8万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 29.8万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 29.8万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 29.8万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 29.8万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 29.8万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 29.8万 - 项目类别:
Standard Grant














{{item.name}}会员




